پھیپھڑوں کا کینسر (نان سمال سیل)
Observation or Upfront Cranial RT in Oncogene Mutated NSCLC With Asymptomatic BM: A Phase III RCT
کہاں جانا ہے
1 ہسپتال انڈیا میں اس ٹرائل کے لیے مریض لے رہا ہے۔
رجسٹری کی سمری (ٹیکنیکل)
Tyrosine Kinase Inhibitors (TKIs) especially higher generation TKI have higher CNS penetration rates and have shown favorable response rates in brain metastases. Brain radiotherapy/surgery is the standard treatment in brain metastases especially symptomatic metastases, however, the role of local treatment especially in driver mutation-positive non-small cell lung cancer with asymptomatic brain metastases is being questioned given their potential side effects. No randomized trial has shown the superiority of early vs delayed cranial RT in asymptomatic BM of driver mutated NSCLC.
سپانسر: ٹاٹا میموریل ہاسپٹل
ClinicalTrials.gov پر NCT05236946
رجسٹری پر آخری اپڈیٹ 10 ستمبر 2025 · ہم نے پڑھا 20 اکتوبر 2026